ONE STOP SOLUTION FOR DRUG DELIVERY
Nanox focuses on the development of pharmaceutical products with complex drug delivery technologies like liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations.
Nanox owns worldwide rights for GM1-Nanomicelles, an innovative carrier for oncological drugs in preclinical stage currently being tested in neuro-oncology indications due its unique capacity to pass the Blood-Brain barrier
Company Details
- Employees
- 10
- Founded
- 2010
- Address
- Le Corbusier 1562, El Triángulo,buenos Aires 1667,argentina
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- nanoxrelease.com
- Keywords
- Drug Delivery, Release Technologies, Liposomes, Nanotechnology, MIcrospheres, Nanomicelles, Neuro-oncology, Oncology, Pegylation, Nanomedicine, Pharmaceutical, Biotechnology, Depot formulations.
- HQ
- El Triángulo, Buenos Aires
Nanox Release Technology S.a. Questions
Nanox Release Technology S.A.'s website is nanoxrelease.com
Nanox Release Technology S.A.'s LinkedIn profile is https://ar.linkedin.com/company/nanox
Nanox Release Technology S.A. has
10 employees.
View email and phone details for 10
employees at Nanox Release Technology S.A..
Nanox Release Technology S.A.'s industry is
Pharmaceutical Manufacturing
Nanox Release Technology S.A.'s top competitors are
Laboratorio Varifarma,
Blipack,
Laboratorios Fabra S.a.,
Centro Pyme Unahur,
Gador,
Bioeliga Srl,
Lipotech S.a.,
Laboratorios Richmond,
Laboratorio Elea,
Millanel Cosmetica.
Nanox Release Technology S.A.'s categories are Pharmaceutical Manufacturing
Nanox Release Technology S.A.'s founding year is 2010
